Your browser doesn't support javascript.
loading
Incorporation of Laboratory Test Biomarkers Into Dual Antiplatelet Therapy Score Improves Prediction of Ischemic and Bleeding Events in Post-percutaneous Coronary Intervention Patients.
Sun, Chengming; Zhong, Lin; Wu, Yanqiu; Cao, Chengfu; Guo, Danjie; Liu, Jie; Gong, Lei; Zhang, Shouxin; Sun, Jun; Yu, Yingqi; Tong, Weiwei; Yang, Jun.
Afiliação
  • Sun C; Department of Clinical Laboratory, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Zhong L; Department of Cardiology, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Wu Y; Medical Information Center, Peking University People's Hospital, Beijing, China.
  • Cao C; Department of Cardiology, Peking University People's Hospital, Beijing, China.
  • Guo D; Department of Cardiology, Peking University People's Hospital, Beijing, China.
  • Liu J; Biochip Laboratory, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Gong L; Biochip Laboratory, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Zhang S; Biochip Laboratory, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Sun J; Biochip Laboratory, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Yu Y; Gennlife (Beijing) Technology Co., Ltd., Beijing, China.
  • Tong W; Gennlife (Beijing) Technology Co., Ltd., Beijing, China.
  • Yang J; Department of Cardiology, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
Front Cardiovasc Med ; 9: 834975, 2022.
Article em En | MEDLINE | ID: mdl-35651911

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China